Douglas Drysdale serves as Executive at PERNIX THERAPEUTICS HOLDINGS, INC., where they oversee executive responsibilities. Since joining the company, Douglas Drysdale has executed 4 insider transactions totaling $142.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 18, 2015 involved purchasing 8,500 shares valued at $39.9K.
Douglas Drysdale currently holds 95,161 shares of PERNIX THERAPEUTICS HOLDINGS, INC. (PTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas Drysdale has been a net buyer of PTX stock. They have purchased $142.3K and sold $0 worth of shares.
Douglas Drysdale's most recent insider trade was on Aug 18, 2015, when they purchased 8,500 shares at $4.69 per share.
Get notified when new Form 4 filings are submitted
| $6.40 |
| Discretionary |
| Aug 8, 2014 | PTX | $712.6K | Disposition | 106,839 | $6.67 | Discretionary |
| Aug 8, 2014 | PTX | $391.9K | Option Exercise | 187,500 | $2.09 | Discretionary |